UnitedHealth Group Incorporated $UNH Stock: Ninety One North America Inc. Boosts Holdings

Ninety One North America Inc. increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,374 shares of the healthcare conglomerate’s stock after buying an additional 2,856 shares during the quarter. Ninety One North America Inc.’s holdings in UnitedHealth Group were worth $5,276,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Nvwm LLC increased its stake in shares of UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock worth $26,000 after acquiring an additional 33 shares during the period. Nalls Sherbakoff Group LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at about $27,000. Wellington Altus USA Inc. boosted its stake in shares of UnitedHealth Group by 97.1% in the second quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 33 shares during the last quarter. Lifetime Wealth Management P.C. acquired a new stake in UnitedHealth Group during the fourth quarter worth about $29,000. Finally, Security National Bank of SO Dak purchased a new position in UnitedHealth Group during the second quarter valued at approximately $29,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded up $14.79 during midday trading on Thursday, reaching $410.41. 5,614,979 shares of the company’s stock traded hands, compared to its average volume of 7,369,734. The company has a fifty day simple moving average of $387.10 and a two-hundred day simple moving average of $383.47. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The company has a market cap of $368.38 billion, a P/E ratio of 23.43, a PEG ratio of 1.41 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.70 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm’s revenue for the quarter was down .4% on a year-over-year basis. During the same period in the prior year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 20.00 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 59.72%.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.19% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on UNH. KeyCorp reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Wednesday. Morgan Stanley boosted their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, August 27th. UBS Group restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday. Finally, Oppenheimer lifted their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a report on Friday, July 17th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $461.48.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings beat and raised guidance: UnitedHealth reported third-quarter revenue of $112.7 billion and adjusted EPS of $4.69, exceeding consensus estimates. Management raised its 2026 adjusted EPS outlook to at least $20.50, above the prior range and analyst expectations. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
• Positive Sentiment: Margin recovery is improving: The medical care ratio improved to 88.4%, while better cost management, pricing discipline and benefit changes supported profitability. Goldman Sachs said Medicare Advantage margins are recovering faster than expected, and UnitedHealth described 2026 as a potential bottom for Medicaid margins. Goldman Sachs report on UNH earnings and margin recovery
• Positive Sentiment: 2027 growth prospects attract bullish analyst views: Management highlighted a potential return to stronger growth, including 13%–16% long-term earnings growth, special-needs Medicare plans, expanded coverage and AI tools that reduce administrative work. Goldman Sachs raised its price target to $506, while Piper Sandler maintained an overweight rating with a $504 target. Can UNH’s focus on special needs plans strengthen Medicare growth?
• Neutral Sentiment: Analyst views remain divided: Piper Sandler and Goldman Sachs see substantial upside, but TD Cowen reaffirmed a hold rating with a $402 target. Barclays and Robert W. Baird also reduced their targets, reflecting uncertainty about the pace of recovery.
• Negative Sentiment: Growth risks remain: Revenue was essentially flat year over year, membership has declined, and investors continue to question the company’s growth path. Commercial medical costs and Medicaid pressure could delay broader margin recovery, leaving some analysts concerned that the recent earnings positives are already reflected in the valuation. UnitedHealth beats on earnings, but investors question growth path

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.